Search Results

You are looking at 1 - 10 of 40 items for :

  • Refine by Access: All content x
Clear All
Open access

Stephanie Burger-Stritt, Linda Bachmann, Max Kurlbaum, and Stefanie Hahner

treatment of acute laryngotracheitis, croup and spastic bronchitis in children, has not been investigated in patients with AI to date. Rectal absorption in case of gastroenteritis and diarrhea is uncertain. Off-label vaginal administration of PN

Open access

Xi Wang and Qi Yu

ovarian tissue leads to intermittent development of ovarian cysts, resulting in vaginal bleeding upon resolution and subsequent oestrogen withdrawal ( 6 , 7 ). Girls typically develop progressive PP marked by recurrent vaginal bleeding, increased breast

Open access

Jennifer K Y Ko, Thomas F J King, Louise Williams, Sarah M Creighton, and Gerard S Conway

total group or 96% or those requiring HRT. Vaginal oestrogens alone ( n  = 1) or together with systemic sex steroids ( n  = 12) were required in 13/141 (9%) women. Table 1 Treatment choices of 141 women with CAIS. Type of HRT n

Open access

Hyun-Ah Kim, Jihye Choi, Chan Sub Park, Min-Ki Seong, Sung-Eun Hong, Jae-Sung Kim, In-Chul Park, Jin Kyung Lee, Woo Chul Noh, and the ASTRRA trial investigators

patients took tamoxifen regardless of their menstrual status during the study. The study design and enrolment criteria are precisely described in a previous report ( 24 ). However, in this study, unlike in the ASTRRA trial, only the presence of vaginal

Open access

Emmanuelle Noirrit, Mélissa Buscato, Marion Dupuis, Bernard Payrastre, Coralie Fontaine, Jean-François Arnal, and Marie-Cécile Valera

-fixed vaginal specimens were stained as previously described ( 28 ) with anti-Ki-67 (RM-9106; ThermoScientific) and anti-ERα antibodies (MC-20, Santa Cruz Biotechnology). Sections were examined after numerization using a NanoZoomer Digital Pathology ® . To

Open access

Elizabeth Micks, Greta B Raglan, and Jay Schulkin

. In one study, 29/74 women in the oral progesterone group vs 44/79 women in the placebo group had a preterm delivery at <37 weeks ( P =0.002) (49) . Decreased risk of preterm delivery has been achieved with vaginal progesterone gel, though one study

Open access

Cecilia Lundin, Agota Malmborg, Julia Slezak, Kristina Gemzell Danielsson, Marie Bixo, Hanna Bengtsdotter, Lena Marions, Ingela Lindh, Elvar Theodorsson, Mats Hammar, and Inger Sundström-Poromaa

assessed intercourse frequency, reported as number of intercourses per day, week or month. The MFSQ questions are categorised into six domains; Sexual Interest, Satisfaction with Frequency of Sexual Activity, Vaginal Lubrication, Orgasm, Partner and

Open access

Kaisu Luiro, Kristiina Aittomäki, Pekka Jousilahti, and Juha S Tapanainen

summarized in Table 1 . All patients had been on HT. In addition, three women were using local vaginal estrogen therapy at the time of the investigation. The median starting age for the use of HT was 18 years (range 15–45), and the median time of use was 22

Open access

Kusum Lata, Pinaki Dutta, Subbiah Sridhar, Minakshi Rohilla, Anand Srinivasan, G R V Prashad, Viral N Shah, and Anil Bhansali

.4 38.0 0.23 Normal vaginal delivery 75 72 0.63 Operative vaginal delivery 4 4 0.99 Lower segment caesarean section (LSCS) 17 22 0.37 Gestational hypertension 6 4 0.75 Preterm labour 12 16 0.41 IUGR 6 4 0.75 Intrahepatic cholestasis of pregnancy 5 4 0

Open access

Paraskevi Kazakou, Stavroula A Paschou, Theodora Psaltopoulou, Maria Gavriatopoulou, Eleni Korompoki, Katerina Stefanaki, Fotini Kanouta, Georgia N Kassi, Meletios-Athanasios Dimopoulos, and Asimina Mitrakou

(101) Adrenalitis (101) Testes Semen virus detection (115) Impaired spermatogenesis (106) Direct virus effect (89, 106) Seminiferous injuries (106) Reduction in Leydig cells number (106) Inflammation (106) Ovaries Vaginal fluid